| Record Information |
| Version |
3.5 |
| Creation Date |
2005-11-16 08:48:42 -0700 |
| Update Date |
2013-05-29 13:31:30 -0600 |
| HMDB ID |
HMDB01414 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
Putrescine |
| Description |
Putrescine is a polyamine. Putrescine is related to cadaverine (another polyamine). Both are produced by the breakdown of amino acids in living and dead organisms and both are toxic in large doses. Putrescine and cadaverine are largely responsible for the foul odor of putrefying flesh, but also contribute to the odor of such processes as bad breath and bacterial vaginosis. Putrescine is also found in semen. Putrescine attacks s-adenosyl methionine and converts it to spermidine. Spermidine in turn attacks another s-adenosyl methionine and converts it to spermine. Putrescine is synthesized in small quantities by healthy living cells by the action of ornithine decarboxylase. The polyamines, of which putrescine is one of the simplest, appear to be growth factors necessary for cell division. Putrescine apparently has specific role in skin physiology and neuroprotection. (PMID: 15009201 , 16364196 ). Pharmacological interventions have demonstrated convincingly that a steady supply of polyamines is a prerequisite for cell proliferation to occur. Genetic engineering of polyamine metabolism in transgenic rodents has shown that polyamines play a role in spermatogenesis, skin physiology, promotion of tumorigenesis and organ hypertrophy as well as neuronal protection. Transgenic activation of polyamine catabolism not only profoundly disturbs polyamine homeostasis in most tissues, but also creates a complex phenotype affecting skin, female fertility, fat depots, pancreatic integrity and regenerative growth. Transgenic expression of ornithine decarboxylase antizyme has suggested that this unique protein may act as a general tumor suppressor. Homozygous deficiency of the key biosynthetic enzymes of the polyamines, ornithine and S-adenosylmethionine decarboxylase is not compatible with murine embryogenesis. |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- 1,4-Butanediamine
- 1,4-Butylenediamine
- 1,4-Diaminobutane
- 1,4-Tetramethylenediamine
- Butylenediamine
- Putrescin
- Tetramethyldiamine
- Tetramethylenediamine
|
| Chemical Formula |
C4H12N2 |
| Average Molecular Weight |
88.1515 |
| Monoisotopic Molecular Weight |
88.100048394 |
| IUPAC Name |
butane-1,4-diamine |
| Traditional IUPAC Name |
putrescine |
| CAS Registry Number |
110-60-1 |
| SMILES |
NCCCCN |
| InChI Identifier |
InChI=1S/C4H12N2/c5-3-1-2-4-6/h1-6H2 |
| InChI Key |
KIDHWZJUCRJVML-UHFFFAOYSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Aliphatic Acyclic Compounds |
| Class |
Alkylamines |
| Sub Class |
Polyamines |
| Other Descriptors |
- Alkylamines
- Biogenic amines(KEGG)
- alkane-alpha,omega-diamine(ChEBI)
|
| Substituents |
|
| Direct Parent |
Polyamines |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
- Component of Arginine and proline metabolism
- Component of Glycine, serine and threonine metabolism
- Component of Histidine metabolism
- Component of Methane metabolism
- Component of Phenylalanine metabolism
- Component of Tryptophan metabolism
- Component of Tyrosine metabolism
- Component of beta-Alanine metabolism
- RNA component
|
| Application |
Not Available
|
| Cellular locations |
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
27.5 °C |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
Not Available |
Not Available |
| LogP |
-0.70 |
SANGSTER (1994) |
|
| Predicted Properties |
|
| Spectra |
|
| Gas-MS Spectrum |
| 13C NMR Spectrum |
| 1H NMR Spectrum |
| MS/MS Spectrum Quattro_QQQ 10 |
| MS/MS Spectrum Quattro_QQQ 25 |
| MS/MS Spectrum Quattro_QQQ 40 |
| MS/MS Spectrum EI-B (HITACHI RMU-6L) |
| MS/MS Spectrum EI-B (HITACHI RMU-6M) |
| MS/MS Spectrum CI-B (HITACHI M-80) |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 10 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 20 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 30 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 40 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 50 |
| MS/MS Spectrum GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) |
| MS/MS Spectrum GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies ) |
| MS/MS Spectrum GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) |
| MS/MS Spectrum LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) |
| [1H,1H] 2D NMR Spectrum |
| [1H,13C] 2D NMR Spectrum |
|
| Biological Properties |
| Cellular Locations |
|
| Biofluid Locations |
- Blood
- Cerebrospinal Fluid (CSF)
- Saliva
- Urine
|
| Tissue Location |
- Muscle
- Fibroblasts
- Neuron
- Placenta
- Testes
- Erythrocyte
- Liver
- Brain
- Prostate
- Skin
- Platelet
|
| Pathways |
| Name |
SMPDB Link |
KEGG Link |
| Methionine Metabolism |
SMP00033
|
map00270
|
| Spermidine and Spermine Biosynthesis |
SMP00445
|
Not Available
|
|
| Normal Concentrations |
|
| Blood |
Detected and Quantified |
|
0.214 +/- 0.08 uM |
Adult (>18 years old) |
Both |
Normal
|
|
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.23 +/- 0.05 uM |
Adult (>18 years old) |
Both |
Normal
|
|
| Saliva |
Detected and Quantified |
|
0.06 uM |
Adult (>18 years old) |
Both |
Normal
|
|
| Urine |
Detected and Quantified |
|
0.35 (0.08-1.06) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal
|
|
| Urine |
Detected but not Quantified |
|
Not Applicable |
Adult (>18 years old) |
Both |
Normal
|
|
| Urine |
Detected and Quantified |
|
0.032 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal
|
|
| Urine |
Detected and Quantified |
|
0.20 (0.04-0.40) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal
|
|
| Urine |
Detected and Quantified |
|
0.076 +/- 0.011 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal
|
|
| Urine |
Detected and Quantified |
|
1.8 +/- 0.46 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal
|
-
Geigy Scient...
-
West Cadwell...
-
Basel, Switz...
|
|
| Abnormal Concentrations |
|
| Urine |
Detected but not Quantified |
|
Not Applicable |
Adult (>18 years old) |
Both |
Leukemia
|
|
| Urine |
Detected and Quantified |
|
0.46 +/- 0.067 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Pancreatic cancer
|
|
|
| Associated Disorders and Diseases |
| Disease References |
| Pancreatic cancer |
- Loser C, Folsch UR, Paprotny C, Creutzfeldt W: Polyamine concentrations in pancreatic tissue, serum, and urine of patients with pancreatic cancer. Pancreas. 1990 Mar;5(2):119-27.
Pubmed: 2315288
|
|
| Associated OMIM IDs |
|
| External Links |
| DrugBank ID |
DB01917  |
| DrugBank Metabolite ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB001494 |
| KNApSAcK ID |
C00001428  |
| Chemspider ID |
13837702  |
| KEGG Compound ID |
C00134  |
| BioCyc ID |
PUTRESCINE  |
| BiGG ID |
33980  |
| Wikipedia Link |
Putrescine  |
| NuGOwiki Link |
HMDB01414  |
| Metagene Link |
HMDB01414  |
| METLIN ID |
3226  |
| PubChem Compound |
1045  |
| PDB ID |
PUT  |
| ChEBI ID |
17148  |
| References |
| Synthesis Reference |
Dudley, H. W.; Thorpe, W. V. Synthesis of N-methylputrescine and of putrescine. Biochemical Journal (1925), 19 845-9. |
| Material Safety Data Sheet (MSDS) |
Not Available
|
| General References |
- Reeben M, Arbatova J, Palgi J, Miettinen R, Halmekyto M, Alhonen L, Janne J, Riekkinen P Sr, Saarma M: Induced expression of neurotrophins in transgenic mice overexpressing ornithine decarboxylase and overproducing putrescine. J Neurosci Res. 1996 Sep 1;45(5):542-8.
Pubmed: 8875319
- Takagi K, Tatsumi Y, Kitaichi K, Iwase M, Shibata E, Nakao M, Matsumoto T, Takagi K, Hasegawa T: A sensitive colorimetric assay for polyamines in erythrocytes using oat seedling polyamine oxidase. Clin Chim Acta. 2004 Feb;340(1-2):219-27.
Pubmed: 14734216
- Harik SI, Sutton CH: Putrescine as a biochemical marker of malignant brain tumors. Cancer Res. 1979 Dec;39(12):5010-5.
Pubmed: 227593
- Gimelli G, Giglio S, Zuffardi O, Alhonen L, Suppola S, Cusano R, Lo Nigro C, Gatti R, Ravazzolo R, Seri M: Gene dosage of the spermidine/spermine N(1)-acetyltransferase ( SSAT) gene with putrescine accumulation in a patient with a Xp21.1p22.12 duplication and keratosis follicularis spinulosa decalvans (KFSD). Hum Genet. 2002 Sep;111(3):235-41. Epub 2002 Aug 1.
Pubmed: 12215835
- Venza M, Visalli M, Cicciu D, Teti D: Determination of polyamines in human saliva by high-performance liquid chromatography with fluorescence detection. J Chromatogr B Biomed Sci Appl. 2001 Jun 5;757(1):111-7.
Pubmed: 11419735
- Halmekyto M, Alhonen L, Alakuijala L, Janne J: Transgenic mice over-producing putrescine in their tissues do not convert the diamine into higher polyamines. Biochem J. 1993 Apr 15;291 ( Pt 2):505-8.
Pubmed: 8484731
- Goldman SS, Volkow ND, Brodie J, Flamm ES: Putrescine metabolism in human brain tumors. J Neurooncol. 1986;4(1):23-9.
Pubmed: 3746382
- El Baze P, Milano G, Verrando P, Renee N, Ortonne JP: Polyamine levels in normal human skin. A comparative study of pure epidermis, pure dermis, and suction blister fluid. Arch Dermatol Res. 1983;275(4):218-21.
Pubmed: 6625645
- Yamazaki H, Tsukahara T, Uki J, Matsuzaki S: Elevated levels of free putrescine and N1-acetylspermidine in cyst fluids of malignant brain tumours. J Neurol Neurosurg Psychiatry. 1986 Feb;49(2):209-10.
Pubmed: 3950641
- Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009 Feb 12;457(7231):910-4.
Pubmed: 19212411
- Janne J, Alhonen L, Pietila M, Keinanen TA: Genetic approaches to the cellular functions of polyamines in mammals. Eur J Biochem. 2004 Mar;271(5):877-94.
Pubmed: 15009201
- Janne J, Alhonen L, Keinanen TA, Pietila M, Uimari A, Pirinen E, Hyvonen MT, Jarvinen A: Animal disease models generated by genetic engineering of polyamine metabolism. J Cell Mol Med. 2005 Oct-Dec;9(4):865-82.
Pubmed: 16364196
|